Skip to content

Author

Vandana Krishna

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Survivin mRNA-lipid nanoparticles promote activation of CD8+Granzyme B+ T cells and effector memory formation for effective oral cancer immunotherapy.

Effective cancer immunotherapy requires an understanding of the tumor microenvironment (TME) to overcome immune suppression and provide a durable anti-tumor response. Here, we present preclinical evaluation of survivin antigen-encoded mRNA lipid nanoparticles (mRNA-LNPs) in a murine oral cancer model. In vivo anti-tumo...

Vandana Krishna, V. K. Venuganti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.